Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unamater is a longevity biotechnology company focused on measuring and managing the biological aging process. Founded by experts in gerontology and health technology, the company provides advanced epigenetic testing to determine an individual's biological age and rate of aging. Unamater integrates these diagnostic insights with personalized health recommendations and interventions designed to optimize healthspan and delay the onset of age-related conditions. The company's mission is to translate the latest breakthroughs in longevity science into accessible, actionable tools for proactive health management. By leveraging proprietary epigenetic clock technology, Unamater aims to provide a scientific foundation for personalized longevity medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UNAMATER.